These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 5067203

  • 1. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Ghiringhelli F, Mazzi C, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
    [No Abstract] [Full Text] [Related]

  • 2. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F, Ongari R, Carazzi R, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
    Pasotti C, Barbieri C, Buniva G, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
    [No Abstract] [Full Text] [Related]

  • 4. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
    Seghezzi R, Borri P, Chierichetti S, Ferrari P.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
    Fumagalli G, Mazzola C, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C, Lumachi B, Marazzi-Uberti E.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Buniva G, Cattò G, Chierichetti S, Granata D, Manieri G.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:258-6. PubMed ID: 4553233
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
    Lumachi B.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:202-4. PubMed ID: 5067193
    [No Abstract] [Full Text] [Related]

  • 11. Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
    Pecorari D, Ragni N, Chierichetti S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:278-8. PubMed ID: 5067205
    [No Abstract] [Full Text] [Related]

  • 12. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S, Pala G, Marazzi-Uberti E, Lumachi B, Crescenzi E, Donetti A, Mantegani A, Bianchi C.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract] [Full Text] [Related]

  • 13. Phenylprenazone in osteoarthritis.
    Cannella M, Curioni GB, Barabino P, Montanari C.
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):52-5. PubMed ID: 4632506
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E, Lumachi B, Gaetani M, Coppi G, Bianchi C.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Pala G, Mantegani A, Donetti A, Lumachi B, Marazzi-Uberti E, Casadio S.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:174-7. PubMed ID: 5067188
    [No Abstract] [Full Text] [Related]

  • 16. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs.
    Bianchi C.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 6. Activity on polyarthritis induced in rats by Freund's adjuvant.
    Lumachi B.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:204+. PubMed ID: 5067194
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G, Bonardi G, Perego R.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A, Ferrari P.
    Minerva Med; 1973 Oct 10; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.